CORC

浏览/检索结果: 共90条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文
BLOOD ADVANCES, 2022, 卷号: 6
作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili
收藏  |  浏览/下载:16/0  |  提交时间:2022/12/23
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载:29/0  |  提交时间:2022/05/05
Tislelizumab (BGB-A317) for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL): Long-term follow-up efficacy and safety results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载:28/0  |  提交时间:2022/01/10
Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study 期刊论文
2019
作者:  Song Yuqin;  Gao Quanli;  Zhang Huilai;  Fan Lei;  Zhou Jianfeng
收藏  |  浏览/下载:16/0  |  提交时间:2020/01/03
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma 期刊论文
2019
作者:  An Gang;  Yan Yuting;  Xu Yan;  Mao Xuehan;  Liu Jiahui
收藏  |  浏览/下载:71/0  |  提交时间:2020/01/03
The impact of response kinetics for multiple myeloma in the era of novel agents 期刊论文
2019, 卷号: 3, 期号: 19, 页码: 2895-2904
作者:  Yan Yuting;  Mao Xuehan;  Liu Jiahui;  Fan Huishou;  Du Chenxing
收藏  |  浏览/下载:29/0  |  提交时间:2020/01/03
Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 期刊论文
BLOOD, 2018, 卷号: 132
作者:  Wang, Aihua;  Hilger, James;  Huang, Jane;  Novotny, William;  Osman, Muhtar
收藏  |  浏览/下载:24/0  |  提交时间:2019/12/05
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文
BLOOD, 2018, 卷号: 132
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 会议论文
作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace